ITGAM and myeloid sarcoma: The present study reveals a novel detrimental role for macrophage (CD11b+) ATX expression in EAE development, urges further studies on LPA homeostasis in MS/EAE pathogenesis and supports potential therapeutic benefits from targeting ATX.